BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31930530)

  • 1. In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer.
    Annunziato S; Lutz C; Henneman L; Bhin J; Wong K; Siteur B; van Gerwen B; de Korte-Grimmerink R; Zafra MP; Schatoff EM; Drenth AP; van der Burg E; Eijkman T; Mukherjee S; Boroviak K; Wessels LF; van de Ven M; Huijbers IJ; Adams DJ; Dow LE; Jonkers J
    EMBO J; 2020 Mar; 39(5):e102169. PubMed ID: 31930530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
    Annunziato S; Kas SM; Nethe M; Yücel H; Del Bravo J; Pritchard C; Bin Ali R; van Gerwen B; Siteur B; Drenth AP; Schut E; van de Ven M; Boelens MC; Klarenbeek S; Huijbers IJ; van Miltenburg MH; Jonkers J
    Genes Dev; 2016 Jun; 30(12):1470-80. PubMed ID: 27340177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
    Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
    Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible Genome Editing with Conditional CRISPR/Cas9 Mice.
    Katigbak A; Robert F; Paquet M; Pelletier J
    G3 (Bethesda); 2018 May; 8(5):1627-1635. PubMed ID: 29519936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern Approaches to Mouse Genome Editing Using the CRISPR-Cas Toolbox and Their Applications in Functional Genomics and Translational Research.
    Monteiro CJ; Heery DM; Whitchurch JB
    Adv Exp Med Biol; 2023; 1429():13-40. PubMed ID: 37486514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing Genetically Engineered Mouse Models (GEMMs) Using CRISPR Mediated Genome Editing.
    Desjardins J; Cowan M; Yamanaka Y
    Methods Mol Biol; 2022; 2429():515-531. PubMed ID: 35507186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel genetically engineered mouse models for clear cell renal cell carcinoma.
    van der Mijn JC; Laursen KB; Fu L; Khani F; Dow LE; Nowak DG; Chen Q; Gross SS; Nanus DM; Gudas LJ
    Sci Rep; 2023 May; 13(1):8246. PubMed ID: 37217526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prime editor mouse to model a broad spectrum of somatic mutations in vivo.
    Ely ZA; Mathey-Andrews N; Naranjo S; Gould SI; Mercer KL; Newby GA; Cabana CM; Rideout WM; Jaramillo GC; Khirallah JM; Holland K; Randolph PB; Freed-Pastor WA; Davis JR; Kulstad Z; Westcott PMK; Lin L; Anzalone AV; Horton BL; Pattada NB; Shanahan SL; Ye Z; Spranger S; Xu Q; Sánchez-Rivera FJ; Liu DR; Jacks T
    Nat Biotechnol; 2024 Mar; 42(3):424-436. PubMed ID: 37169967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient production of large deletion and gene fragment knock-in mice mediated by genome editing with Cas9-mouse Cdt1 in mouse zygotes.
    Mizuno-Iijima S; Ayabe S; Kato K; Matoba S; Ikeda Y; Dinh TTH; Le HT; Suzuki H; Nakashima K; Hasegawa Y; Hamada Y; Tanimoto Y; Daitoku Y; Iki N; Ishida M; Ibrahim EAE; Nakashiba T; Hamada M; Murata K; Miwa Y; Okada-Iwabu M; Iwabu M; Yagami KI; Ogura A; Obata Y; Takahashi S; Mizuno S; Yoshiki A; Sugiyama F
    Methods; 2021 Jul; 191():23-31. PubMed ID: 32334080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Solanum tuberosum GBSSI gene: a target for assessing gene and base editing in tetraploid potato.
    Veillet F; Chauvin L; Kermarrec MP; Sevestre F; Merrer M; Terret Z; Szydlowski N; Devaux P; Gallois JL; Chauvin JE
    Plant Cell Rep; 2019 Sep; 38(9):1065-1080. PubMed ID: 31101972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies.
    Fan HH; Yu IS; Lin YH; Wang SY; Liaw YH; Chen PL; Yang TL; Lin SW; Chen YT
    FASEB J; 2019 Apr; 33(4):5571-5584. PubMed ID: 30640520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting protein function in vivo: Engineering allelic series in mice using CRISPR-Cas9 technology.
    Cassidy AM; Kuliyev E; Thomas DB; Chen H; Pelletier S
    Methods Enzymol; 2022; 667():775-812. PubMed ID: 35525561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
    Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
    Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 Endonuclease-Mediated Mouse Genome Editing of One-Cell and/or Two-Cell Embryos by Electroporation, and the Use of Rad51 to Enhance Knock-In Allele Homozygosity via Interhomolog Repair Mechanism.
    Garza S; Paik R
    Methods Mol Biol; 2023; 2631():253-266. PubMed ID: 36995671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 Toolkit for Genome Editing in an Autotrophic CO
    Li J; Zhang L; Xu Q; Zhang W; Li Z; Chen L; Dong X
    Microbiol Spectr; 2022 Aug; 10(4):e0116522. PubMed ID: 35766512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient CRISPR/Cas9-based gene knockout in watermelon.
    Tian S; Jiang L; Gao Q; Zhang J; Zong M; Zhang H; Ren Y; Guo S; Gong G; Liu F; Xu Y
    Plant Cell Rep; 2017 Mar; 36(3):399-406. PubMed ID: 27995308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portable CRISPR-Cas9
    Goh YJ; Barrangou R
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.